Prof Sir Chris Evans
26 January 2022
Prof. Sir Chris Evans OBE is a highly successful and internationally renowned scientific entrepreneur. He has launched, financed and built more than 40 life sciences companies from their inception and now valued in excess of $7 billion. Twenty of these companies were listed on six separate stock exchanges around the world during a career spanning 35 years. Sir Chris has returned $billions in cash to investors. Notable companies include Ellipses Pharma, Excalibur Healthcare Services, Chiroscience, Celsis, BioVex, ReNeuron, Vectura, Piramed, Arakis, Arix, Rutherford clinics and Merlin Biosciences Ltd.
Appointed OBE in 1995 for services to medical bioscience, he was then one of the youngest scientists to be knighted in 2001 for services to bioscience and enterprise. He has advised four UK Prime Ministers on pharmaceutical, life sciences and healthcare policy over the year as well as overseas governments including Algeria, Libya, Malta, Qatar and the United Arab Emirates.
He holds numerous professorships, fellowships and honorary doctorates in science at some 16 British universities and he has been the author of more than 100 scientific publications and patents.
Sir Chris has raised more than $3billion of investment for research projects, developing over 50 innovative medical products. Sir Chris has always had a strong focus on cancer research and clinical development of new cancer medicines and has raised more than $2billion for cancer research projects over the years.
He has a keen interest in rugby, wine, beer, health and fitness and music.
Back to all Events